Provided by Tiger Trade Technology Pte. Ltd.

Plus Therapeutics, Inc.

0.3027
-0.0216-6.66%
Post-market: 0.30320.0005+0.17%16:54 EST
Volume:5.24M
Turnover:1.58M
Market Cap:53.99M
PE:-0.66
High:0.3194
Open:0.3150
Low:0.2910
Close:0.3243
52wk High:2.31
52wk Low:0.1634
Shares:178.37M
Float Shares:178.37M
Volume Ratio:0.81
T/O Rate:2.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4560
EPS(LYR):-1.9544
ROE:-522.50%
ROA:-65.58%
PB:10.68
PE(LYR):-0.15

Loading ...

Plus Therapeutics prices 39.5M units at 38c in upsized public offering

TIPRANKS
·
Jan 14

Plus Therapeutics Inc - Each Unit Sold at $0.38, Gross Proceeds Expected $15 Mln

THOMSON REUTERS
·
Jan 14

Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering

GlobeNewswire
·
Jan 14

BRIEF-Plus Therapeutics Announces Read Out Of Type B Meeting With The FDA

Reuters
·
Jan 08

Plus Therapeutics Announces Read Out of Type B Meeting With the FDA With Goal of Accelerating Approval of Reyobiq™ for Leptomeningeal Metastases

THOMSON REUTERS
·
Jan 08

Plus Therapeutics Inc - FDA Recommends Study Evaluate Endpoint With Clinical Benefit

THOMSON REUTERS
·
Jan 08

Plus Therapeutics Inc - FDA Indicates Accelerated Approval May Be Appropriate for Lm

THOMSON REUTERS
·
Jan 08

CNSide Diagnostics Expands CNSide Assay Platform to California

Reuters
·
Dec 11, 2025

Plus Therapeutics Grants Stock Options and RSUs to New CNSide Diagnostics Hires

Reuters
·
Dec 09, 2025

Plus Therapeutics completes FDA meeting on REYOBIQ development plans

TIPRANKS
·
Nov 24, 2025

Plus Therapeutics Inc : Ascendiant Capital Markets Cuts Target Price to $19 From $21

THOMSON REUTERS
·
Nov 21, 2025

Plus Therapeutics’ assay secures national coverage agreement with Humana

TIPRANKS
·
Nov 20, 2025

Plus Therapeutics CFO Andrew Sims Reports Acquisition of Common Shares

Reuters
·
Nov 05, 2025

Plus Therapeutics Q3 net loss widens

Reuters
·
Oct 31, 2025

Plus Therapeutics Q3 Net Income USD -4.423 Million

Reuters
·
Oct 31, 2025

Plus Therapeutics Q3 Operating Income USD -4.482 Million

THOMSON REUTERS
·
Oct 31, 2025

Plus Therapeutics Reports Third Quarter Financial Results and Recent Business Highlights

THOMSON REUTERS
·
Oct 31, 2025

Plus Therapeutics provides update on CNSide Diagnostic platform launch

TIPRANKS
·
Oct 21, 2025

Press Release: Plus Therapeutics Updates on CNSide(R) Diagnostic Platform Launch

Dow Jones
·
Oct 21, 2025

Plus Therapeutics announces national coverage agreement with UnitedHealthcare

TIPRANKS
·
Sep 25, 2025